Richard Moscicki

Richard A. Moscicki currently serves as Deputy Center Director-Science Operations at the Center for Drug Evaluation & Research since 2013.
He is Director at KSQ Therapeutics, Inc. since 2018.
He holds the position of Independent Non-Executive Director at CANbridge Pharmaceuticals Inc. starting in 2026.
He is also Senior Vice President at Genzyme Ltd. Formerly, he was Chairman at LogicBio Therapeutics, Inc. from 2020 to 2022.
He was Deputy Center Director-Science Operations at the US Food & Drug Administration from 2013 to 2017.
He served as Independent Director at Akcea Therapeutics, Inc. from 2018 to 2020.
He was Chief Medical Officer & SVP-Clinical Development at Genzyme Corp.
from 1992 to 2011.
He was a Staff Member at The General Hospital Corp.
He was Chief Immunology & Allergy Officer at Massachusetts Eye & Ear Infirmary, Inc. He was Senior VP & Head-Clinical Development at Genzyme Therapeutics Ltd. from 2011 to 2013.
He was Chief Medical Officer at Pharmaceutical Research & Manufacturers of America from 2017 to 2022.
Education includes a doctorate from Feinberg School of Medicine and an undergraduate degree from Northwestern University conferred in 1974.